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Purpose
To describe the causes of death occurring within the first
month following the diagnosis of JSLE in order to prevent
them.
Methods
Retrospective study of causes of early death in JSLE
patients during the period 1995 – 2006 conducted on
behalf of Paediatric Rheumatology International Trials
Organization (PRINTO). All the patients fulfilled the
American College of Rheumatology (ACR) criteria for the
diagnosis of SLE, and were diagnosed before 16 years of
age.
Results
Death was recorded in 5 girls and 1 boy including three
non Caucasian patients, aged 6 to 16 years. Initial SLE
manifestations comprised at least three organ involve-
ment, including at least two major organ involvement:
central nervous system (4 patients), kidney (5 patients),
pancreas (2 patients), hematopoietic system (3 patients),
heart (1 patient), skin (2 patients), and joints (3 patients).
Despite administration of oral and pulsed steroids, asso-
ciated twice with intravenous cyclophosphamide, SLE
activity remained uncontrolled in all the patients. Death
resulted from SLE organ failure either alone in 2 patients
(pancreatitis: 1 patient, neurolupus: 1 patient), either
associated with thrombotic event (catastrophic antiphos-
pholipid syndrome: 2 patients, pulmonary thromboem-
bolism: 1 patient with nephrotic syndrome) and/or
infection (paravertebral abcess: 1 patient, pneumococcal
sepsis: 1 patient).
Conclusion
Despite prompt diagnosis and management, death may
occur at presentation of juvenile-onset SLE. Half of them
resulted from thromboembolic event in patients with
nephrotic syndrome or APL. These features suggest that
prompt prophylactic anticoagulation may be beneficial in
patients with severe SLE multiorgan involvements associ-
ated with risk factors of thromboembolic event.
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